High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$7.7M
$7,705,163
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Daniell Richard
• Officer • EVP, Europe Commercial
10b5-1 SellΔOwn -16.8%
2026-03-05
$547,705
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • EVP, Europe Commercial
10b5-1 SellΔOwn -16.8%
|
2026-03-05 | $547,705 | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Daniell Richard
• Officer • EVP, Europe Commercial
10b5-1 SellΔOwn -14.2%
2026-03-04
$2,983,517Largex3
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • EVP, Europe Commercial
10b5-1 SellΔOwn -14.2%
|
2026-03-04 | $2,983,517Largex3 | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Daniell Richard
• Officer • EVP, Europe Commercial
10b5-1 SellΔOwn -35.1%
2026-03-03
$4,173,942Largex2
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • EVP, Europe Commercial
10b5-1 SellΔOwn -35.1%
|
2026-03-03 | $4,173,942Largex2 | S | Form 4 |